Abstract:Abstract Objectives The value of using PET/CT for staging of stage I–II NPC remains unclear. Hence, we aimed to investigate the survival benefit of PET/CT for staging of early-stage NPC before radical therapy. Methods A total of 1003 patients with pathologically confirmed NPC of stages I–II were consecutively enrolled. Among them, 218 patients underwent both PET/CT and conventional workup ([CWU], head-and-neck MRI, chest radiograph, liver ultrasound, bone scintigraphy) before treatment. The remaining 785 patients only underwent CWU. The standard of truth (SOT) for lymph node metastasis was defined by the change of size according to follow-up MRI. The diagnostic efficacies were compared in 218 patients who underwent both PET/CT and CWU. After covariate adjustment using propensity scoring, a cohort of 872 patients (218 with and 654 without pre-treatment PET/CT) was included. The primary outcome was overall survival based on intention to treat. Results Retropharyngeal lymph nodes were metastatic based on follow-up MRI in 79 cases. PET/CT was significantly less sensitive than MRI in detecting retropharyngeal lymph node lesions (72.2% [62.3–82.1] vs. 91.1% [84.8–97.4], p = 0.004). Neck lymph nodes were metastatic in 89 cases and PET/CT was more sensitive than MRI (96.6% [92.8–100.0] vs. 76.4% [67.6–85.2], p < 0.001). In the survival analyses, there was no association between pre-treatment PET/CT use and improved overall survival, progression-free survival, local relapse-free survival, regional relapse-free survival, and distant metastasis-free survival. Conclusions This study showed PET/CT is of little value for staging of stage I–II NPC patients at initial imaging. Key Points • PET/CT was more sensitive than MRI in detecting neck lymph node lesions whereas it was significantly less sensitive than MRI in detecting retropharyngeal lymph node lesions. • No association existed between pre-treatment PET/CT use and improved survival in stage I–II NPC patients.

Meta-analysis of Diagnostic Value Of18f-Fdg PET or PET/CT for Detecting Lymph Node and Distant Metastases in Patients with Nasopharyngeal Carcinoma

Optimal Modality for Detecting Distant Metastasis in Primary Nasopharyngeal Carcinoma During Initial Staging: A Systemic Review and Meta-analysis of 1774 Patients.

The role of PET-CT in diagnosing distant metastasis of nasopharyngeal carcinoma

Significant value of 18 F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

The Value of 18F-FDG PET/CT in N Staging Nasopharyngeal Carcinoma Patients

[Role of 18F-FDG PET/CT in Diagnosis and Staging of Nasopharyngeal Carcinoma].

[18F]FDG PET/CT Versus [18F]FDG PET/MRI in the Diagnosis of Lymph Node Metastasis in Nasopharyngeal Carcinoma: a Systematic Review and Meta-Analysis

[Meta-Analysis of PET/CT for Diagnosis of Residual/recurrent Nasopharyngeal Carcinoma].

Use of 18F-FDG PET/CT in the Diagnosis, Staging, Response Assessment and Prognosis of Nasopharyngeal Carcinoma: an Updated Review

A head-to-head comparison of 2-[18F]FDG PET/CT and 2-[18F]FDG PET/MR in patients with nasopharyngeal carcinoma under different disease settings

Prospective Study of Tailoring Whole-Body Dual-Modality [18f]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography with Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging

Prognostic Value of Pretreatment 18F-FDG PET-CT for Nasopharyngeal Carcinoma Patients.

A head-to-head comparison of 18F-FDG PET/CT and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma under different disease settings

[Comparison Between PET/CT and MRI in Diagnosing Lymph Node Metastasis and N Staging of Nasopharyngeal Carcinoma].

A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma

Positron emission tomography/computed tomography outperforms MRI in the diagnosis of local recurrence and residue of nasopharyngeal carcinoma: An update evidence from 44 studies.

Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I–II nasopharyngeal carcinoma: a nest case-control study

Comparison between PET-CT and MRI in diagnosing nodal metastasis of nasopharyngeal carcinoma]

Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma

A Comparative Study of 18F-FLT PET/CT and 18F-FDG PET/CT in Patients with Nasopharyngeal Carcinoma